Adipose-derived stem cell exosomes loaded with icariin alleviates rheumatoid arthritis by modulating macrophage polarization in rats

  • J Nanobiotechnology. 2024 Jul 18;22(1):423. doi: 10.1186/s12951-024-02711-1.
Qiqi Yan  #  1 ,  Haixia Liu  1 ,  Shiyue Sun  2 ,  Yongsheng Yang  2 ,  DanPing Fan  3 ,  Yuqin Yang  1 ,  Yukun Zhao  1 ,  Zhiqian Song  1 ,  Yanjing Chen  1 ,  Ruyuan Zhu  #  4 ,  Zhiguo Zhang  #  5
Affiliations
  • 1. Institute of Basic Theory for Chinese Medicine, China Academy of Chinese Medical Sciences, Beijing, China.
  • 2. Institute of Acupuncture and Moxibustion, China Academy of Chinese Medical Sciences, Beijing, China.
  • 3. Institute of Experimental Research Center, China Academy of Chinese Medical Sciences, Beijing, China.
  • 4. Institute of Basic Theory for Chinese Medicine, China Academy of Chinese Medical Sciences, Beijing, China. [email protected].
  • 5. Institute of Basic Theory for Chinese Medicine, China Academy of Chinese Medical Sciences, Beijing, China. [email protected].
  • # Contributed equally.
PMID: 39026367 DOI: 10.1186/s12951-024-02711-1
Abstract

Rheumatoid Arthritis (RA) is a chronic Autoimmune Disease marked by synovitis and cartilage destruction. The active compound, icariin (ICA), derived from the herb Epimedium, exhibits potent anti-inflammatory properties. However, its clinical utility is limited by its water insolubility, poor permeability, and low bioavailability. To address these challenges, we developed a multifunctional Drug Delivery system-adipose-derived stem cells-exosomes (ADSCs-EXO)-ICA to target active Macrophages in synovial tissue and modulate macrophage polarization from M1 to M2. High-performance liquid chromatography analysis confirmed a 92.4 ± 0.008% loading efficiency for ADSCs-EXO-ICA. In vitro studies utilizing cellular immunofluorescence (IF) and flow cytometry demonstrated significant inhibition of M1 macrophage proliferation by ADSCs-EXO-ICA. Enzyme-linked immunosorbent assay, cellular transcriptomics, and real-time quantitative PCR indicated that ADSCs-EXO-ICA promotes an M1-to-M2 phenotypic transition by reducing Glycolysis through the inhibition of the ERK/HIF-1α/GLUT1 pathway. In vivo, ADSCs-EXO-ICA effectively accumulated in the joints. Pharmacodynamic assessments revealed that ADSCs-EXO-ICA decreased cytokine levels and mitigated Arthritis symptoms in collagen-induced Arthritis (CIA) rats. Histological Analysis and micro computed tomography confirmed that ADSCs-EXO-ICA markedly ameliorated synovitis and preserved cartilage. Further in vivo studies indicated that ADSCs-EXO-ICA suppresses Arthritis by promoting an M1-to-M2 switch and suppressing Glycolysis. Western blotting supported the therapeutic efficacy of ADSCs-EXO-ICA in RA, confirming its role in modulating macrophage function through Energy Metabolism regulation. Thus, this study not only introduces a Drug Delivery system that significantly enhances the anti-RA efficacy of ADSCs-EXO-ICA but also elucidates its mechanism of action in macrophage function inhibition.

Keywords
A novel drug delivery system—adipose-derived stem cells-exosomes (ADSCs-EXO)-ICA; Adipose-derived stem cell exosomes; Collagen-induced arthritis; Macrophage polarization; Rheumatoid arthritis; Synergistic effect; icariin.
Products